Company research
AVAI BIO, INC.
CIK 1740797Updated Sep 24, 2026
SecurityAVAI · OTC · equity
Name history
AVANT TECHNOLOGIES INC. · through Feb 9, 2026TREND INNOVATIONS HOLDING INC. · through Jul 19, 2023FREECOOK · through Jun 5, 2020
AVAI price & chart
Loading TradingView…
OTC:AVAI on TradingView ↗In the news
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them ↗
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration News provided by USA News Group Jan 29, 2026, 13:31 ET Share this article Share to X Share this article Share to X Issued on behalf of Avant Technologies Inc. VANCOUVER, BC , Jan. 29, 2026 /PRNewswire/ -- USA Ne ↗
SEC disclosures
AVAI BIO, INC. files 8-K: Material Event ↗
Recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 572,696Source | 224,745Source | 322,014Source | 454,664Source |
| Property, Plant and Equipment, NetUSD | 1,500Source | — | 1,500Source | 1,500Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 131,612Source | 205,932Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 23,145Source | 81,053Source | 281Source | 33,289Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | — | 3,765Source |
| Assets, CurrentUSD | 89,340Source | 93,133Source | 116,082Source | 330,872Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | 12,080Source | — | — |
| Other Assets, NoncurrentUSD | 377,814Source | — | — | -131,394Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,387,851Source | 1,788,617Source | 1,788,580Source | 860,225Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 11,300Source | 11,300Source | 10,000Source | 3,950Source |
| Common Stock, Value, IssuedUSD | 153,212Source | 137,364Source | 117,168Source | 26,316Source |
| Additional Paid in CapitalUSD | 2,873,102Source | 2,390,724Source | 1,367,411Source | 60,193Source |
| Retained Earnings (Accumulated Deficit)USD | -5,868,019Source | -4,118,510Source | -2,976,395Source | 495,851Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | — | 169Source |
| Stockholders' Equity Attributable to ParentUSD | -2,815,155Source | -1,563,872Source | -1,466,566Source | -405,561Source |
| Liabilities and EquityUSD | 572,696Source | 224,745Source | 322,014Source | 454,664Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 3,387,851Source | 1,788,617Source | 1,788,580Source | 860,225Source |
| Accounts Payable, CurrentUSD | 1,592,882Source | 885,267Source | 1,081,803Source | 1,986Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | — | — | 2,816Source |
| Long-term Debt, Current MaturitiesUSD | 24,918Source | 112,520Source | — | 99,000Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | -1,142,115Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 26,070Source | 74,320Source | 76,953Source | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | 59,864Source |
| Increase (Decrease) in Accounts PayableUSD | 707,615Source | -196,536Source | 844,903Source | 268,936Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -1,009,844Source | -1,160,610Source | -1,322,318Source | 535,008Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | -149,000Source | -33,719Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 951,936Source | 1,241,382Source | 1,364,127Source | 474,214Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | -27,075Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 23,145Source | 81,053Source | 281Source | 33,289Source |
| Additional Financial Items | ||||
| DepreciationUSD | 1,500Source | — | 1,500Source | — |
| General and Administrative ExpenseUSD | 792,265Source | 762,478Source | 1,424,334Source | 449,361Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | 126,521Source |
| Net Income (Loss) Attributable to ParentUSD | -1,749,509Source | -1,142,115Source | -2,128,475Source | -126,521Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -1,749,509Source | — | — | -126,521Source |
| Nonoperating Income (Expense)USD | — | — | -11,293Source | — |
| Operating ExpensesUSD | 1,480,191Source | 1,532,792Source | 2,117,182Source | 553,920Source |
| Other Operating Income (Expense), NetUSD | — | — | — | 216,605Source |
| Proceeds from Issuance of Common StockUSD | 15,848Source | — | 78,664Source | — |
| Proceeds from Issuance of Long-term DebtUSD | 140,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2022 |
|---|---|---|---|---|
| Cost of RevenueUSD | — | — | — | 710,512Source |
| Operating Income (Loss)USD | -1,749,509Source | -1,142,115Source | -2,128,475Source | 126,521Source |
| Net Income (Loss) Attributable to ParentUSD | -1,749,509Source | -1,142,115Source | -2,128,475Source | -126,521Source |
| Earnings Per Share, BasicUSD per share | -0.01Source | -0.01Source | -0.02Source | 0Source |
| Total Revenue | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 137,974,247Source | 128,148,099Source | 86,532,015Source | 26,316,083Source |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | 26,070Source | 74,320Source | 76,953Source | — |
| General and Administrative ExpenseUSD | 792,265Source | 762,478Source | 1,424,334Source | 449,361Source |
| Gross ProfitUSD | — | — | — | -210,794Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | 126,521Source |
| Interest Income (Expense), NetUSD | — | — | — | 921,306Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -1,749,509Source | — | — | -126,521Source |
| Net Investment IncomeUSD | — | — | — | 126,521Source |
| Nonoperating Income (Expense)USD | — | — | -11,293Source | — |
| Operating ExpensesUSD | 1,480,191Source | 1,532,792Source | 2,117,182Source | 553,920Source |
| Other IncomeUSD | — | 390,677Source | — | — |
| Other Operating Income (Expense), NetUSD | — | — | — | 216,605Source |
| Research and Development ExpenseUSD | 15,000Source | — | — | — |